Now, the prime questions are ” How long way we need to drive on COVID-19 ” ?
How valuable lives need to be counted ? How many people shall be write their name on the list of indigent or poor ? How much shall be the Financial loss and the Loss of Mental & Physical strength of people ? How many more things ?????
The math will not be simple to calculate losses due COVID-19 pandemic across the globe.
As we know that, we have been fighting with Coronavirus since 31 December, 2019 or more than that. Throughout this journey, we have already lost 124,544 nos. of valuable lives and about 2 millions people are battling with the COVID-19.
Financially, according to economictimes.indiatimes, the Asia-Pacific region could face a total and permanent income loss of $620 billion owing to the impact of the Covid-19 pandemic, according to the latest S&P Global Ratings update released on Monday. The global ratings agency further slashed its growth estimate for the region to 2.7% in 2020, from an earlier downgrade to 3% just last week on Wednesday.
On 8 April, 2020, The World Trade Organization (WTO) is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world . For more information – WTO Report.
The coronavirus could cost the global economy more than $1tn in lost output if it turns into a pandemic, according to a leading economic forecaster.
Earlier about one and half month later, on 19 February, 2020 (The Guardian), Oxford Economics warned that the spread of the virus to regions outside Asia would knock 1.3% off global growth this year, the equivalent of $1.1tn in lost income.
According to UNITED NATIONS, Nearly 25 million jobs could be lost worldwide due to the coronavirus pandemic, but an internationally coordinated policy response can help lower the impact on global unemployment, according to a UN agency.
Reprot on 5 March, 2020 at Business Insider, as coronavirus cases continue to rise around the world, a group of Australian experts predict that the economic impact of the disease in the best-case scenario may total $2.4 trillion in lost global gross domestic product. Whereas, In the high-severity model — modeled after the Spanish flu pandemic, which killed an estimated 17 million to 50 million globally from 1918 to 1920 — the global GDP loss could be as high as $9 trillion. In that model, the death toll is estimated to surpass 68 million.
5th January, 2020: Pneumonia of unknown cause – China
On 31 December 2019, the WHO China Country Office was informed of cases of pneumonia of unknown etiology (unknown cause) detected in Wuhan City, Hubei Province of China. As of 3 January 2020, a total of 44 patients with pneumonia of unknown etiology have been reported to WHO by the national authorities in China. Of the 44 cases reported, 11 are severely ill, while the remaining 33 patients are in stable condition. According to media reports, the concerned market in Wuhan was closed on 1 January 2020 for environmental sanitation and disinfection.
The causal agent has not yet been identified or confirmed. On 1 January 2020, WHO requested further information from national authorities to assess the risk.
For more information:
- Infection prevention and control of epidemic-and pandemic prone acute respiratory infections in health care, WHO guidelines:
- Wuhan Municipal Health Commission briefing on the pneumonia epidemic situation, 31 December 2019 (in Mandarin):
- Wuhan Municipal Health Commission briefing on the pneumonia epidemic situation 3 January 2020 (in Mandarin):
12th January, 2020: Novel Coronavirus – China
On 11 and 12 January 2020, WHO received further detailed information from the National Health Commission about the outbreak.
WHO is reassured of the quality of the ongoing investigations and the response measures implemented in Wuhan, and the commitment to share information regularly.
The evidence is highly suggestive that the outbreak is associated with exposures in one seafood market in Wuhan. The market was closed on 1 January 2020. At this stage, there is no infection among healthcare workers, and no clear evidence of human to human transmission. The Chinese authorities continue their work of intensive surveillance and follow up measures, as well as further epidemiological investigations.
Among the 41 confirmed cases, there has been one death. This death occurred in a patient with serious underlying medical conditions.
China shared the genetic sequence of the novel coronavirus on 12 January, which will be of great importance for other countries to use in developing specific diagnostic kits.
The cluster was initially reported on 31 December 2019, when the WHO China Country Office was informed. The Chinese authorities identified a new type of coronavirus (novel coronavirus, nCoV), which was isolated on 7 January 2020. Laboratory testing was conducted on all suspected cases identified through active case finding and retrospective review. Other respiratory pathogens such as influenza, avian influenza, adenovirus, Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), Middle East Respiratory Syndrome coronavirus (MERS-CoV) were ruled out as the cause.
According to information conveyed to WHO by Chinese authorities on 11 and 12 January, 41 cases with novel coronavirus infection have been preliminarily diagnosed in Wuhan City. Of the 41 cases reported, seven are severely ill. This is when the one death, mentioned above, was reported, in a patient with other underlying health conditions. Six patients have been discharged from hospital. Symptom onset of the 41 confirmed nCoV cases ranges from 8 December 2019 to 2 January 2020. No additional cases have been detected since 3 January 2020.
The clinical signs and symptoms reported are mainly fever, with a few cases having difficulty in breathing, and chest radiographs showing invasive pneumonic infiltrates in both lungs. National authorities report that patients have been isolated and are receiving treatment in Wuhan medical institutions.
According to the preliminary epidemiological investigation, most cases worked at or were handlers and frequent visitors to the Huanan Seafood Wholesale Market. The government reports that there is no clear evidence that the virus passes easily from person to person.
Currently, no case with infection of this novel coronavirus has been reported elsewhere other than Wuhan.
Based on information provided by national authorities, WHO’s recommendations on public health measures and surveillance for novel coronaviruses apply.
WHO does not recommend any specific health measures for travellers. In case of symptoms suggestive of respiratory illness either during or after travel, travellers are encouraged to seek medical attention and share travel history with their healthcare provider. Travel guidance has been updated.
WHO advises against the application of any travel or trade restrictions on China based on the information currently available on this event.
For more information:
- Technical guidance for novel coronavirus, WHO
- Wuhan Municipal Health Commission briefing on the pneumonia epidemic situation, 31 December 2019 (in Chinese)
- Wuhan Municipal Health Commission briefing on the pneumonia epidemic situation 3 January 2020 (in Chinese)
- Wuhan Municipal Health Commission’s briefing on the pneumonia epidemic situation, 5 January 2020 (in Chinese)
- Wuhan Municipal Health Commission’s briefing on the pneumonia epidemic situation, 11 January 2020 (in Chinese)
- Wuhan Municipal Health Commission’s Experts interpretation of the outbreak update, 11 January 2020 (in Chinese)
- WHO travel advice for international travel and health in relation to the outbreak of pneumonia caused by a new coronavirus in China